Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
145.4 EUR | -1.02% | -5.36% | +1.53% |
10:09am | MERCK KGAA : Barclays reiterates its Buy rating | ZD |
Apr. 18 | Study: US companies outpace Europe and Asia in research spending | DP |
Sales 2024 * | 21.25B 22.64B | Sales 2025 * | 22.5B 23.98B | Capitalization | 63.8B 67.98B |
---|---|---|---|---|---|
Net income 2024 * | 2.97B 3.17B | Net income 2025 * | 3.48B 3.7B | EV / Sales 2024 * | 3.32 x |
Net Debt 2024 * | 6.79B 7.24B | Net Debt 2025 * | 4.83B 5.15B | EV / Sales 2025 * | 3.05 x |
P/E ratio 2024 * |
21.5
x | P/E ratio 2025 * |
18.3
x | Employees | 62,908 |
Yield 2024 * |
1.57% | Yield 2025 * |
1.65% | Free-Float | 29.71% |
Latest transcript on Merck KGaA
1 day | -1.11% | ||
1 week | -5.36% | ||
Current month | -10.65% | ||
1 month | -7.38% | ||
3 months | -0.48% | ||
6 months | -3.03% | ||
Current year | +1.53% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 20-07-12 | |
Marcus Kuhnert
DFI | Director of Finance/CFO | 56 | 14-07-31 |
Director of Finance/CFO | 53 | 19-04-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Raabe
BRD | Director/Board Member | - | - |
Chairman | 67 | 19-04-25 | |
Gabriele Eismann
BRD | Director/Board Member | 62 | 90-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 145.6 | -0.89% | 0 |
24-04-18 | 146.8 | 0.00% | 1,033 |
24-04-17 | 146.8 | -3.23% | 403 |
24-04-16 | 151.8 | -0.72% | 202 |
24-04-15 | 152.8 | -0.62% | 0 |
Delayed Quote Deutsche Boerse AG, April 19, 2024 at 02:20 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.08% | 9.12B | |
-15.94% | 4.8B | |
+18.47% | 3.72B | |
+1.89% | 3.8B | |
+25.99% | 2.58B | |
-24.63% | 2.36B | |
-29.37% | 2.11B | |
+2.55% | 1.86B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- MRK Stock
- MRK Stock